Construction on the site will begin in the fall and is expected to be finished by 2027. North Chicago is already home to ...

Erythroid cell patterns in neoplasms show distinct genomic profile and poor venetoclax response, new research suggests.

AbbVie Inc.'s Q2 2025 results showcase Skyrizi & Rinvoq's growth, strong finances, and a promising pipeline. Click for my ...

AbbVie, the maker of Botox, Humira, and Rinvoq, will invest $195 million to expand its North Chicago manufacturing facility, ...

AbbVie (NYSE:ABBV) invests $195M in North Chicago for API production, boosting U.S. pharmaceutical manufacturing. Read more ...

AbbVie, a global leader in life sciences, announced Tuesday the company’s is investing $195 million to expand its North ...

As pharma companies big and small play up their U.S. investment plans during the second Trump administration, the particulars ...

AbbVie (NYSE: ABBV) today announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the U.S. This ...

Governor JB Pritzker, AbbVie, and the Illinois Department of Commerce and Economic Opportunity (DCEO) have announced a ...

Key opinion leaders (KOLs) interviewed by GlobalData have expressed the need for therapies with higher efficacy to improve ...

NORTH CHICAGO Governor JB Pritzker, AbbVie, and the Illinois Department of Commerce and Economic Opportunity (DCEO) today ...

AbbVie is investing $195 million to build a new north Chicago manufacturing plant to expand its active pharmaceutical ingredient production in the U.S. The investment is part of the biopharmaceutical ...